Prostate MRI Using Deep Learning Reconstruction in Response to Cancer Screening Demands-A Systematic Review and Meta-Analysis.

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Stephan Ursprung, Georgios Agrotis, Petra J van Houdt, Leon C Ter Beek, Thierry N Boellaard, Regina G H Beets-Tan, Derya Yakar, Anwar R Padhani, Ivo G Schoots
{"title":"Prostate MRI Using Deep Learning Reconstruction in Response to Cancer Screening Demands-A Systematic Review and Meta-Analysis.","authors":"Stephan Ursprung, Georgios Agrotis, Petra J van Houdt, Leon C Ter Beek, Thierry N Boellaard, Regina G H Beets-Tan, Derya Yakar, Anwar R Padhani, Ivo G Schoots","doi":"10.3390/jpm15070284","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: There is a growing need for efficient prostate MRI protocols due to their increasing use in managing prostate cancer (PCa) and potential inclusion in screening. Deep learning reconstruction (DLR) may enhance MR acquisitions and improve image quality compared to conventional acceleration techniques. This systematic review examines DLR approaches to prostate MRI. <b>Methods</b>: A search of PubMed, Web of Science, and Google Scholar identified eligible studies comparing DLR to conventional reconstruction for prostate imaging. A narrative synthesis was performed to summarize the impact of DLR on acquisition time, image quality, and diagnostic performance. <b>Results</b>: Thirty-three studies showed that DLR can reduce acquisition times for T<sub>2</sub>w and DWI imaging while maintaining or improving image quality. It did not significantly affect clinical tasks, such as biopsy decisions, and performed comparably to human readers in PI-RADS scoring and the detection of extraprostatic extension. However, AI models trained on conventional data might be less accurate with DLR images. The heterogeneity in image quality metrics among the studies prevented quantitative synthesis. <b>Discussion</b>: DLR has the potential to achieve substantial time savings in prostate MRI while maintaining image quality, which is especially relevant because of increased MRI demands. Future research should address the effect of DLR on clinically relevant downstream tasks, including AI algorithms' performances and biopsy decisions, and explore task-specific accelerated protocols for screening, image-guided biopsy, and treatment.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 7","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12298121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15070284","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: There is a growing need for efficient prostate MRI protocols due to their increasing use in managing prostate cancer (PCa) and potential inclusion in screening. Deep learning reconstruction (DLR) may enhance MR acquisitions and improve image quality compared to conventional acceleration techniques. This systematic review examines DLR approaches to prostate MRI. Methods: A search of PubMed, Web of Science, and Google Scholar identified eligible studies comparing DLR to conventional reconstruction for prostate imaging. A narrative synthesis was performed to summarize the impact of DLR on acquisition time, image quality, and diagnostic performance. Results: Thirty-three studies showed that DLR can reduce acquisition times for T2w and DWI imaging while maintaining or improving image quality. It did not significantly affect clinical tasks, such as biopsy decisions, and performed comparably to human readers in PI-RADS scoring and the detection of extraprostatic extension. However, AI models trained on conventional data might be less accurate with DLR images. The heterogeneity in image quality metrics among the studies prevented quantitative synthesis. Discussion: DLR has the potential to achieve substantial time savings in prostate MRI while maintaining image quality, which is especially relevant because of increased MRI demands. Future research should address the effect of DLR on clinically relevant downstream tasks, including AI algorithms' performances and biopsy decisions, and explore task-specific accelerated protocols for screening, image-guided biopsy, and treatment.

前列腺MRI使用深度学习重建响应癌症筛查需求-系统回顾和荟萃分析。
背景/目的:由于前列腺MRI在前列腺癌(PCa)治疗和筛查中的应用越来越广泛,因此对高效前列腺MRI方案的需求日益增长。与传统的加速技术相比,深度学习重建(DLR)可以增强MR采集并改善图像质量。本系统综述探讨DLR入路前列腺MRI。方法:检索PubMed, Web of Science和b谷歌Scholar,确定了比较DLR与传统前列腺成像重建的合格研究。通过叙述综合来总结DLR对采集时间、图像质量和诊断性能的影响。结果:33项研究表明,DLR可以减少T2w和DWI成像的采集次数,同时保持或提高图像质量。它没有显著影响临床任务,如活检决定,并且在PI-RADS评分和前列腺外展检测方面与人类阅读器相当。然而,在传统数据上训练的人工智能模型在DLR图像上可能不太准确。研究中图像质量指标的异质性阻碍了定量综合。讨论:DLR有潜力在保持图像质量的同时节省前列腺MRI的大量时间,这在MRI需求增加的情况下尤为重要。未来的研究应解决DLR对临床相关下游任务的影响,包括人工智能算法的性能和活检决策,并探索特定任务的筛选、图像引导活检和治疗加速方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信